Biolocity is a philanthropic, multi-institutional network supporting university medical technology commercialization in the southeast. Through a combination of investment, project management, consulting, and educational programming, Biolocity provides early-stage, patient impacting technologies the resources needed to reach critical commercialization milestones. In October 2019, the Coulter Translational Program re-branded to Biolocity, expanding our funding and commercialization support opportunities. The program continues to be stewarded by the Biomedical Engineering Department of Georgia Institute of Technology and Emory University.